Deep brain stimulation of the subthalamic nucleus: Clinical effectiveness and safety

Neurology

Volumn 56, Issue 4, 2001, Pages 552-554

  Lopiano, Leonardo ^a   Rizzone, M ^a   Bergamasco, B ^a   Tavella, A ^a   Torre, E ^a   Perozzo, P ^a   Valentini, M C ^b   Lanotte, M ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b CTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RATING SCALE; SAFETY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 0035957064     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.4.552     Document Type: Article

References (7)

1. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease
2. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease
3. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation
4. Long-term electrical inhibition of deep brain targets in movement disorders
5. Core assessment program for intracerebral transplantations (CAPIT)
6. The Unified Parkinson's Disease Rating scale